Sining Hu

Sining Hu

Auto-generated profile, based on publicly available information

Sining Hu

Harbin Medical University, Ministry of Education

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2025 in Circulation: Cardiovascular Imaging
Verified
Journal Article
Closed access
QSQianhui Sun
Qianhui Sun
SWShengfang Wang
Shengfang Wang
MZMing Zeng
Ming Zeng
MLMinghao Liu
Minghao Liu
CZChen Zhao
Chen Zhao
HJHaibo Jia
Haibo Jia
BACKGROUND: Clonal hematopoiesis of indeterminate potential is a novel, nontraditional risk factor linked to coronary heart disease. DNMT3A and TET2 are the 2 most prevalent clonal hematopoiesis of indeterminate potential-associated driver genes. This study aims to evaluate their effects on plaque characteristics and prognosis in patients with ST-segment–elevation myocardial infarction. METHODS: Consecutive patients with ST-segment–elevation myocardial infarction (May 2017–May 2019) undergoing routine optical coherence tomography were enrolled. Targeted deep exome sequencing of peripheral blood (custom panel targeting DNMT3A and TET2 ) identified mutations (with a threshold variant allele frequency ≥2%). The primary end point was major adverse cardiovascular events, defined as a composite end point that includes all-cause death, nonfatal myocardial infarction, nonfatal stroke, and revascularization due to clinical ischemic events. RESULTS: Among 628 patients, 12.3% were identified as carriers of DNMT3A or TET2 gene mutations. Patients with DNMT3A/TET2 mutations were older (62.5 versus 55.6 years; P <0.001), while the 2 groups showed comparable prevalence rates of hypertension (48.1% versus 43.2%), diabetes (22.1% versus 22.3%), and dyslipidemia (53.2% versus 61.7%). Carriers demonstrated greater plaque vulnerability characteristics on optical coherence tomography, including a higher macrophage proportion, smaller minimal lumen area, thinner fibrous cap, and higher lipid index. During a median follow-up of 2.4 years (interquartile range 2.0–3.0), major adverse cardiovascular events rates were significantly higher in the mutation group (39.5% versus 19.9%; P <0.001). Both DNMT3A/TET2 mutations (adjusted hazard ratio, 1.91 [95% CI, 1.19–3.07]; P =0.008) and TET2 mutations specifically (adjusted hazard ratio, 3.57 [95% CI, 1.78–7.17]; P <0.001) independently predicted major adverse cardiovascular events occurrence in patients with ST-segment–elevation myocardial infarction. CONCLUSIONS: Patients with ST-segment–elevation myocardial infarction and DNMT3A/TET2 mutations exhibit vulnerable characteristics in their coronary plaques, along with an increased risk of experiencing major adverse cardiovascular events. Moreover, carrying TET2 mutations confers a worse prognosis compared with solely having DNMT3A mutations.

5 September 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
MSManru Shi
Manru Shi
QLQuan Lin
Quan Lin
SFShaohong Fang
Shaohong Fang
CMCheng Ma
Cheng Ma
WXWeiwei Xu
Weiwei Xu
MEMingyan E
Mingyan E
Background: Cardiac issues following radiotherapy are increasingly prevalent among patients with thoracic cancer and coronary disease. However, the mechanisms underlying radiotherapy‐induced plaque instability and changes in plaque characteristics on imaging remain unclear. This study used single‐cell RNA sequencing to identify key features of vulnerable plaques following radiotherapy. Methods: We applied dual‐mode synchronized optical coherence tomography‐intravascular ultrasound imaging in a rabbit model to reveal the characteristics of vulnerable plaques at various time points postradiotherapy. We then conducted single‐cell RNA sequencing on atherosclerotic lesions from A poE −/− (apolipoprotein E −/− ) mice across 3 stages: nonirradiated, early irradiation, and advanced irradiation. Bioinformatics was used to analyze cell populations, trajectories, and interaction differences among the groups. This was followed by pathological staining, flow cytometry, gene knockout, and antibody depletion. Results: In vivo optical coherence tomography‐intravascular ultrasound imaging at the initial stage accurately evaluated radiation exposure's effect on the stability of rabbit carotid plaques. High‐throughput single‐cell transcriptomics mapped the radiotherapy‐induced immune system remodeling in atherosclerotic lesions, and identified a granzyme K + CD8 + (cluster of differentiation 8 + ) T‐cell subpopulation. The infiltrating cells highly expressed the cytotoxic molecule GZMB (granzyme B) in the plaques. The absence of CD8 + T cells or GZMB ameliorated radiotherapy‐exacerbated atherosclerotic lesions. This demonstrates the pathogenic function of GZMK + (granzyme K + ) CD8 + cytotoxic T cells in promoting radiotherapy‐induced atherosclerotic lesion progression. Conclusions: We identified characteristic arterial imaging changes resulting from radiation injury, accurately and dynamically assessing the effects of radiation exposure on plaque stability. Radiation exposure affected plaque stability by modulating GZMK + CD8 + T‐cell activation and GZMB function, suggesting GZMB as a mediator of radio‐cardiovascular injury and a potential therapeutic target.

15 December 2025 in Vessel Plus
Verified
Journal Article
Closed access
XWXiaoyu Wei
Xiaoyu Wei
MLMan Li
Man Li
ZCZiyang Cui
Ziyang Cui
WWWentao Wang
Wentao Wang
SSShuangtong Shao
Shuangtong Shao
SHSining Hu
Sining Hu
Atherosclerosis (AS) is a chronic inflammatory disease initiated by abnormal subendothelial lipid deposition in blood arteries. Although endothelial dysfunction, lipid homeostasis imbalance, and clonal proliferation of vascular smooth muscle cells are central to classical theories, recent studies have shown that immune cells such as neutrophils, T lymphocytes, and macrophages dynamically infiltrate the plaque microenvironment. This evidence suggests that the immune regulatory network plays a significant role in the pathological process of AS. It should be noted that female patients exhibit distinct clinical phenotypes and pathological characteristics during AS. This sex difference is closely related to changes in sex hormone levels, such as estrogen, as well as to differences in inflammatory responses and metabolic regulation. Studies aiming to control the progression of AS by targeting immune mechanisms unique to women remain in the exploratory stage, and their potential mechanisms of action and regulation have not yet been well clarified. This study will systematically elucidate immune activity and provide a theoretical basis for effective intervention strategies for cardiovascular disease in women, focusing on immunological remodeling and the relationship between sex and immunity in AS.